Infectious Disease Control Global News & Press Release Distribution

Infectious Disease Control

All
APAC

iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model.

* Secured the effectiveness confirming data of PHAGERIA® technology for colorectal cancer organoids * The first target cancer type of PHAGERIA® technology is colorectal cancer (CRC) BOSTON and SEOUL, South Korea, April 3, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",www.intodeworld.com...

2023-04-04 10:33 2233

RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer

BOSTON, March 17, 2023 /PRNewswire/ -- RVAC Medicines (US), Inc., a messenger RNA (mRNA) technology company with its global headquarters inSingapore, today announced the collaboration under a Sponsored Research Agreement with the University of Pennsylvania ("Penn") focused on the discovery and dev...

2023-03-17 21:00 3897

Assure Tech Launches a New Platform - Comprehensive Health Solution

HANGZHOU, China, March 6, 2023 /PRNewswire/ -- With the rapid development of the social economy and the continuous improvement in people's living standard, pets, especially cats and dogs, have gradually become important family members in modern times.World wide, strong demand for pet-related prod...

2023-03-06 18:47 1391

Assure Tech Launches a New Platform - Comprehensive Health Solution

The first case of COVID pregnant mother in Guangzhou was successfully delivered by cesarean section and the newborn was in good condition; doctors treat pregnant COVID-19 patient Under Quarantine Protection

The First Case of Successful Delivery of Patient with COVID-19 in Guangzhou GUANGZHOU, China, Feb. 27, 2023 /PRNewswire/ -- "Mother and daughter are safe, the child is 2.85 kilograms." In the early morning ofNovember 1st, director of the Department of Obstetrics and Gynecology, Liang Huichao said...

2023-02-27 17:18 1880

The first case of COVID pregnant mother in Guangzhou was successfully delivered by cesarean section and the newborn was in good condition; doctors treat pregnant COVID-19 patient Under Quarantine Protection

Huichao Liang, An Expert on AIDS Combined with Gynecological Oncology, Receives Excellent Popular Science Worker Award

GUANGZHOU, China, Feb. 24, 2023 /PRNewswire/ -- In 2022, the selection of outstanding popular science workers inGuangzhou was successfully concluded. Dr. Huichao Liang from the Guangzhou Eighth People's Hospital, Guangzhou Medical University was ranked on the list and awarded the title of "Excell...

2023-02-24 16:37 1785

Huichao Liang, An Expert on AIDS Combined with Gynecological Oncology, Receives Excellent Popular Science Worker Award

GC Biopharma Receives WHO Pre-Qualification for BARYCELA

YONGIN, South Korea, Feb. 19, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that the World Health Organization (WHO) has granted prequalification for BARYCELA, GC Biopharma's varicella vaccine. WHO prequalificatio...

2023-02-20 09:38 2014

Global Times: Small and mid-sized cities in China go through infection peak, bearing new hope for future

BEIJING, Feb. 1, 2023 /PRNewswire/ -- As media sources around the world have paid so much attention to infection surges in various metropolises or first-and-second-tier cities inChina and governments at all levels have attached great importance to anti-epidemic work in rural areas, a review on ho...

2023-02-01 22:45 2327

Global Times: Having weathered epidemic storms overseas, Chinese return to hometown for safe, joyous Spring Festival reunions

BEIJING, Jan. 31, 2023 /PRNewswire/ -- Red lanterns are once again hung in the contemporary houses that combine Chinese and Western elements in the famous hometown of overseas Chinese in East China'sFujian Province. For countless overseas Chinese, this year's Spring Festival provided an opportun...

2023-01-31 22:10 2376

Global Times: 'So much better than we had anticipated': China's rural regions embrace Spring Festival as COVID peak ebbs away

BEIJING, Jan. 31, 2023 /PRNewswire/ -- The Spring Festival is rooted in agricultural civilization. Chinese people believe the most traditional atmosphere of Spring Festival is in rural regions. Since the prevention and control of the COVID-19 epidemic has entered a new stage, questions have been...

2023-01-31 21:41 2304

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

* SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in theKingdom of Saudi Arabia(KSA) * SK bioscience also explained a new global partnership model aiming to promote public health in deve...

2023-01-27 20:00 4120

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

Looking Back on Three Years of COVID-19 in China

BEIJING, Jan. 13, 2023 /PRNewswire/ -- A news report from Beijing Review: A lantern fair in Shanghai’s Yuyuan Garden attracts crowds of visitors on January 12, 2023 (WEI YAO) Entering ...

2023-01-13 22:29 3994

Looking Back on Three Years of COVID-19 in China

Global Times: Connected in recognition: Foreign ambassadors signal a welcome for China's optimized, responsible COVID policy

BEIJING, Jan. 11, 2023 /PRNewswire/ -- As of January 8, China downgraded the management of COVID-19 from category A to the less serious category B infectious disease in light of the evolving epidemic. The Chinese government has optimized measures to combat the epidemic in accordance with the soci...

2023-01-11 18:24 1993

Global Times: 'Zhang Wenhong phenomenon' shows inclusiveness of China's public opinion sphere; policymaking based on science helps nation firmly hold strategic initiative of epidemic fight

BEIJING, Jan. 11, 2023 /PRNewswire/ -- On Friday, China released the 10th edition of the COVID-19 prevention and control protocol. Moreover, starting from Sunday, the country downgraded the management of COVID-19 from Class A to Class B and lifted quarantine requirements for inbound travelers. Th...

2023-01-11 17:49 1756

Global Times: China shifts COVID policy with necessary conditions

BEIJING, Jan. 5, 2023 /PRNewswire/ -- After three years' hard efforts to keep COVID-19 at bay,China has optimized its virus response and come up with a major shift in its epidemic policy by downgrading COVID management and announcing the reopening of international borders fromJanuary 8, 2023. Glo...

2023-01-05 23:21 1973

China enters new stage in COVID-19 response

BEIJING, Dec. 29, 2022 /PRNewswire/ -- A news report by China.org.cn on China's COVID-19 response: &amp;nbsp; Changes are taking place to China's COVID-19 response. Now, efforts are being accelerated across the country to fully reopen the economy, and people are generally no longer requ...

2022-12-29 22:00 2555

Global Times: Three years' hard effort to fight COVID-19 'worthwhile'

BEIJING, Dec. 28, 2022 /PRNewswire/ -- After three years' hard effort to keep the COVID-19 at bay,China has optimized its virus responses recently. The Global Times has talked with front line medical workers, grass-roots community workers and others about their experience in the three-year battle...

2022-12-28 21:38 2191

PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT

NANJING, China, Dec. 20, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced today that, XIANNUOXIN (SIM0417), an anti-SARS-CoV-2 drug candidate jointly developed by Simcere with Shanghai Institute ofMateria Medica (the "SIMM") and Wuhan Institute of Virology (the "WIV"), Chines...

2022-12-20 19:21 2167

E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control

FUZHOU, China, Dec. 14, 2022 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services inChina, today announced that the Company's subsidiary Zhongrun (Fujian) Pharmaceutical Co., Ltd. ("Zhongrun") plan to expa...

2022-12-14 21:30 2667

Epidemic: Modified approach ensures maximum benefit

BEIJING, Dec. 12, 2022 /PRNewswire/ -- A report from chinadaily.com.cn: After three years of battling COVID-19, experts said China is seeing the light at the end of the tunnel as it continues to optimize measures against the epidemic.

2022-12-13 11:42 1690

Epidemic: Modified approach ensures maximum benefit

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") (Nasdaq: IRAA), a publicly traded special purpose acquisition company ...

2022-12-05 20:00 1566

123 4 5 ... 13